GDF9 antibody (C-Term)
Quick Overview for GDF9 antibody (C-Term) (ABIN7877390)
Target
See all GDF9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Binding Specificity
- C-Term
-
Purpose
- GDF9 Antibody (azide and preservative free)
-
Sequence
- VPAKYSPLSV LTIEPDGSIA YKEYEDMIAT KC
-
Purification
- Protein G affinity chromatography
-
Immunogen
- Amino acids VPAKYSPLSVLTIEPDGSIAYKEYEDMIATKC from the C-terminal region of human GDF9 were used as the immunogen for the GDF9 antibody. The epitope has been mapped to amino acids EPDG.
-
Isotype
- IgG1
-
-
-
-
Application Notes
- Optimal dilution of the GDF9 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the GDF9 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- GDF9 (Growth Differentiation Factor 9 (GDF9))
-
Alternative Name
- GDF9
-
Background
- GDF9 is a member of the bone morphogenetic protein (BMP) family and the TGF-beta superfamily. This group of proteins is characterized by a polybasic proteolytic processing site which is cleaved to produce a mature protein containing seven conserved cysteine residues. The members of this family are regulators of cell growth and differentiation in both embryonic and adult tissues. Growth factors synthesized by ovarian somatic cells directly affect oocyte growth and function. GDF9 is expressed in oocytes and is thought to be required for ovarian folliculogenesis. GDF9/4261 can be used in assays to detect oocyte expression and has been shown to neutralize GDF9 biological activity.
-
UniProt
- O60383
Target
-